Wells Trecaso Financial Group, LLC Novartis Ag Transaction History

Wells Trecaso Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$70.67 - $99.01 $180,279 - $252,574	-2,551 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$84.35 - $95.37 $17,291 - $19,550	205 Added 8.74%	2,551 $241,000
Q3 2019 Oct 16, 2019	SELL	$85.54 - $94.26 $769 - $848	-9 Reduced 0.38%	2,346 $204,000
Q2 2019 Jul 22, 2019	BUY	$75.4 - $92.8 $11,385 - $14,012	151 Added 6.85%	2,355 $215,000
Q1 2019 Apr 18, 2019	BUY	$75.32 - $86.15 $166,005 - $189,874	2,204 New	2,204 $212,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Wells Trecaso Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wells Trecaso Financial Group, LLC with notifications on news.